Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumor

J. L. Summers, J. S. Coon, R. M. Ward, W. H. Falor, A. W. Miller, Ronald S Weinstein

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Several markers of initial bladder carcinomas described recently may be clinically sigificant predictors of biological behavior of future recurrences. Comparison of the marker systems and assessment of the value of using multiple markers have been difficult, because the various markers have been studied in different patients. In this study, we compared four markers [chromosome mode, marker chromosomes, and expression of the ABH 'blood group' antigens and the Thomsen-Friedenreich antigen (using immunoperoxidase or lectin immunoperoxidase methods)] in 39 patients presenting initially with low-stage bladder carcinoma and followed 3 to 11 years or until deep muscle invasion occurred. Each of the markers was significantly related to subsequent recurrences with deep muscle invasion, and each marker system was able to identify those patients with a very low risk of subsequent invasion. For detection of a subpopulation of patients with Grade II carcinomas who were at high risk for development of subsequent invasion, combinations of markers, especially hyperdiploidy and abnormal expression of the Thomsen-Friedenreich antigen, were significantly more effective than any single marker system.

Original languageEnglish (US)
Pages (from-to)934-939
Number of pages6
JournalCancer Research
Volume43
Issue number2
StatePublished - 1983
Externally publishedYes

Fingerprint

ABO Blood-Group System
Karyotype
Urinary Bladder
Carcinoma
Genetic Markers
Neoplasms
Recurrence
Muscles
Polyploidy
Blood Group Antigens
Lectins
Thomsen-Friedenreich antigen

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumor. / Summers, J. L.; Coon, J. S.; Ward, R. M.; Falor, W. H.; Miller, A. W.; Weinstein, Ronald S.

In: Cancer Research, Vol. 43, No. 2, 1983, p. 934-939.

Research output: Contribution to journalArticle

@article{535787cbcc264314ac5ddf15405f7b99,
title = "Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumor",
abstract = "Several markers of initial bladder carcinomas described recently may be clinically sigificant predictors of biological behavior of future recurrences. Comparison of the marker systems and assessment of the value of using multiple markers have been difficult, because the various markers have been studied in different patients. In this study, we compared four markers [chromosome mode, marker chromosomes, and expression of the ABH 'blood group' antigens and the Thomsen-Friedenreich antigen (using immunoperoxidase or lectin immunoperoxidase methods)] in 39 patients presenting initially with low-stage bladder carcinoma and followed 3 to 11 years or until deep muscle invasion occurred. Each of the markers was significantly related to subsequent recurrences with deep muscle invasion, and each marker system was able to identify those patients with a very low risk of subsequent invasion. For detection of a subpopulation of patients with Grade II carcinomas who were at high risk for development of subsequent invasion, combinations of markers, especially hyperdiploidy and abnormal expression of the Thomsen-Friedenreich antigen, were significantly more effective than any single marker system.",
author = "Summers, {J. L.} and Coon, {J. S.} and Ward, {R. M.} and Falor, {W. H.} and Miller, {A. W.} and Weinstein, {Ronald S}",
year = "1983",
language = "English (US)",
volume = "43",
pages = "934--939",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumor

AU - Summers, J. L.

AU - Coon, J. S.

AU - Ward, R. M.

AU - Falor, W. H.

AU - Miller, A. W.

AU - Weinstein, Ronald S

PY - 1983

Y1 - 1983

N2 - Several markers of initial bladder carcinomas described recently may be clinically sigificant predictors of biological behavior of future recurrences. Comparison of the marker systems and assessment of the value of using multiple markers have been difficult, because the various markers have been studied in different patients. In this study, we compared four markers [chromosome mode, marker chromosomes, and expression of the ABH 'blood group' antigens and the Thomsen-Friedenreich antigen (using immunoperoxidase or lectin immunoperoxidase methods)] in 39 patients presenting initially with low-stage bladder carcinoma and followed 3 to 11 years or until deep muscle invasion occurred. Each of the markers was significantly related to subsequent recurrences with deep muscle invasion, and each marker system was able to identify those patients with a very low risk of subsequent invasion. For detection of a subpopulation of patients with Grade II carcinomas who were at high risk for development of subsequent invasion, combinations of markers, especially hyperdiploidy and abnormal expression of the Thomsen-Friedenreich antigen, were significantly more effective than any single marker system.

AB - Several markers of initial bladder carcinomas described recently may be clinically sigificant predictors of biological behavior of future recurrences. Comparison of the marker systems and assessment of the value of using multiple markers have been difficult, because the various markers have been studied in different patients. In this study, we compared four markers [chromosome mode, marker chromosomes, and expression of the ABH 'blood group' antigens and the Thomsen-Friedenreich antigen (using immunoperoxidase or lectin immunoperoxidase methods)] in 39 patients presenting initially with low-stage bladder carcinoma and followed 3 to 11 years or until deep muscle invasion occurred. Each of the markers was significantly related to subsequent recurrences with deep muscle invasion, and each marker system was able to identify those patients with a very low risk of subsequent invasion. For detection of a subpopulation of patients with Grade II carcinomas who were at high risk for development of subsequent invasion, combinations of markers, especially hyperdiploidy and abnormal expression of the Thomsen-Friedenreich antigen, were significantly more effective than any single marker system.

UR - http://www.scopus.com/inward/record.url?scp=0020678336&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020678336&partnerID=8YFLogxK

M3 - Article

C2 - 6848204

AN - SCOPUS:0020678336

VL - 43

SP - 934

EP - 939

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 2

ER -